All articles tagged with #hivaids
The United States is moving away from the centralized PEPFAR framework to a patchwork of bilateral country partnerships, prompting concerns about reduced oversight and weaker data collection just as HIV testing, PrEP uptake, and pediatric treatment decline; experts warn the pace could hinder ongoing progress toward ending the epidemic, despite PEPFAR's historic impact.
Doctors Without Borders (MSF) is pressing Gilead to directly sell lenacapavir, a two-a-year injectable PrEP for HIV prevention, to MSF for use in its humanitarian programs. Gilead has refused, directing MSF to obtain doses through the Global Fund, which has a limited supply, leaving many vulnerable people without access. MSF cites humanitarian need and calls for an urgent meeting by April 13 to decide pricing and delivery timelines.
In Fiji, international crime networks use the archipelago as a meth transit hub, with weekly drop-offs in a squatter settlement where dealers package white crystals for about $22 a dose; the drug trade exacerbates a growing HIV epidemic among people who inject drugs, highlighted by community safe spaces such as Survival Advocacy Network that offer HIV testing and support.
Florida is narrowing eligibility for its HIV Drug Assistance Program, risking coverage for about 16,000 residents; starting March 1, only households earning up to 130% of the federal poverty line (about $21,000) will qualify, down from 400% (around $64,000). The move comes as ACA subsidies expire and drug costs rise, threatening uninterrupted antiretroviral treatment for patients like Tori Samuel and potentially increasing viral rebound and transmission. State officials say the changes prevent a funding shortfall amid rising costs, while advocates warn the policy could undermine public health and prompt legal challenges.
Peter Duesberg, once a celebrated virologist, argued HIV did not cause AIDS and helped seed today’s anti-science movement; his claims were debunked, but his influence persists through figures like RFK Jr. who weaponize distrust of public health, shaping policy and vaccine skepticism with deadly consequences.
Florida’s Department of Health is trimming the AIDS Drug Assistance Program to avert a projected $120 million funding shortfall after Congress did not extend ACA tax credits, potentially depriving about 10,000 low‑income Floridians living with HIV/AIDS of affordable medications starting March 1, with eligibility narrowed to the poorest residents.
Kofi Okyere Darko (KOD) encourages tourists to visit Ghana during December, despite reports of robbery and rising HIV/AIDS cases, emphasizing that these issues should be addressed through education and that crime is not unique to Ghana.
David Baltimore, a pioneering virologist whose discovery of reverse transcriptase revolutionized understanding of retroviruses and contributed significantly to cancer and HIV/AIDS research, has passed away at age 87. His work challenged the central dogma of molecular biology and provided essential tools for modern genetic research.
The UN proposes to close UNAIDS by 2026 due to funding cuts, with plans to integrate its expertise into the broader UN system, amid ongoing challenges in global HIV/AIDS efforts.
The US has suspended some funding for its key HIV/AIDS relief program, PEPFAR, leading to disruptions in treatment and prevention efforts worldwide, with unclear impacts due to lack of data and ongoing budget disputes.
A federal appeals court ruled that President Trump can continue to withhold over $10 billion in foreign aid funds allocated by Congress for global health and HIV/AIDS programs, reversing a lower court decision and citing lack of legal standing for aid groups to sue. The ruling highlights ongoing disputes over the administration's approach to foreign aid and congressional authority.
PEPFAR, the U.S. initiative to combat HIV/AIDS, narrowly avoided significant funding cuts in 2023, which caused disruptions in clinics and treatment programs worldwide. While the program's future remains uncertain due to expired authorization and shifting priorities, some experts see a renewed bipartisan commitment and a move towards increased international ownership, though challenges persist in maintaining progress against HIV/AIDS globally.
Despite past successes in reducing tuberculosis (TB) deaths, the disease saw a resurgence in the 1980s and 1990s due to factors like the HIV/AIDS epidemic, drug resistance, and increased migration from high-burden countries. The global burden was underestimated for years, leading to a delayed response. Improved data collection and international efforts have since helped reduce TB deaths, but it remains a major health challenge, especially in lower-income countries. The article emphasizes the importance of good data and sustained global efforts to finally control and eliminate TB.
Charlize Theron expressed concern over the devastating impact of foreign aid cuts, particularly highlighting the risk of millions of deaths from HIV/AIDS in South Africa, and emphasized the importance of resistance and activism to oppose such policies. She also discussed broader issues of human rights and social justice.
The article marks the end of the AIDS/LifeCycle event after 31 years, highlighting its history, personal significance to the author who has participated for 26 years, and its impact in raising over $300 million for HIV/AIDS services. It discusses the origins of the ride, its beneficiaries, personal motivations for participating, and the challenges faced due to rising costs and decreasing awareness among younger generations. The author emphasizes the importance of continued fundraising and advocacy amidst political challenges, and shares personal achievements and statistics related to his involvement.